{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:34:13Z","timestamp":1787690053745,"version":"build-2784847793"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine and Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.resmer.2023.101006","type":"journal-article","created":{"date-parts":[[2023,3,5]],"date-time":"2023-03-05T02:50:08Z","timestamp":1677984608000},"page":"101006","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A foetus with cystic fibrosis \u2013 To treat or not to treat?"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3592-6124","authenticated-orcid":false,"given":"Nikita","family":"Padmakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haji Sheeraz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resmer.2023.101006_bib0001","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.3390\/jcm9092706","article-title":"CFTR modulators: impact on fertility, pregnancy, and lactation in women with cystic fibrosis","volume":"9","author":"Taylor-Cousar","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.resmer.2023.101006_bib0002","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/pir.2019-0212","article-title":"Cystic fibrosis","volume":"42","author":"Dickinson","year":"2021","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.resmer.2023.101006_bib0003","unstructured":"Cystic Fibrosis Trust (2019). FAQs. Cysticfibrosis.org.uk. Available at: https:\/\/www.cysticfibrosis.org.uk\/what-is-cystic-fibrosis\/faqs [Accessed 4 September 2022]."},{"key":"10.1016\/j.resmer.2023.101006_bib0004","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet North Am Ed"},{"key":"10.1016\/j.resmer.2023.101006_bib0005","article-title":"Digestive outcomes in cystic fibrosis","volume":"56\u201357","author":"Ley","year":"2022","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.resmer.2023.101006_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcf.2020.02.018","article-title":"Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators \u2013 an international survey","volume":"19","author":"Nash","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101006_bib0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fped.2022.914790","article-title":"The exocrine pancreas in cystic fibrosis in the era of CFTR modulation: a mini review","volume":"10","author":"McKay","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.resmer.2023.101006_bib0008","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/cells11010054","article-title":"Bicarbonate transport in cystic fibrosis and pancreatitis","volume":"11","author":"Angyal","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.resmer.2023.101006_bib0009","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.resmer.2023.101006_bib0010","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MOP.0000000000000934","article-title":"Pancreatic complications in children with cystic fibrosis","volume":"32","author":"Sellers","year":"2020","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.resmer.2023.101006_bib0011","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/ppul.25065","article-title":"Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor","volume":"55","author":"Munce","year":"2020","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.resmer.2023.101006_bib0012","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.jcf.2021.03.018","article-title":"Normal pancreatic function and false-negative CF newborn screen in a child born to a mother taking CFTR modulator therapy during pregnancy","volume":"20","author":"Fortner","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101006_bib0013","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jcf.2018.05.009","article-title":"Measured fetal and neonatal exposure to lumacaftor and ivacaftor during pregnancy and while breastfeeding","volume":"17","author":"Trimble","year":"2018","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101006_bib0014","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jcf.2022.04.005","article-title":"A case report of CFTR modulator administration via carrier mother to treat meconium ileus in a F508del homozygous fetus","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101006_bib0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2022-001289","article-title":"Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design","volume":"9","author":"Jain","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"10.1016\/j.resmer.2023.101006_bib0016","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/j.chest.2021.07.024","article-title":"Fertility and pregnancy in cystic fibrosis","volume":"160","author":"Shteinberg","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resmer.2023.101006_bib0017","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.21037\/tau.2020.04.05","article-title":"Genetics of CFTR and male infertility","volume":"10","author":"Bieniek","year":"2021","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.resmer.2023.101006_bib0018","doi-asserted-by":"crossref","DOI":"10.1095\/biolreprod.113.110403","article-title":"A genome-wide analysis of open chromatin in human epididymis epithelial cells reveals candidate regulatory elements for genes coordinating epididymal function","volume":"89","author":"Bischof","year":"2013","journal-title":"Biol Reprod"},{"key":"10.1016\/j.resmer.2023.101006_bib0019","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.jcf.2019.08.024","article-title":"Female reproductive health in cystic fibrosis","volume":"18","author":"Hughan","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101006_bib0020","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jcf.2020.12.011","article-title":"Elexacafator\/tezacaftor\/ivacaftor resolves subfertility in females with CF: a two center case series","volume":"20","author":"O'Connor","year":"2021","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.resmer.2023.101006_bib0021","unstructured":"Updated commissioning statement ivacaftor, tezacaftor\/ivacaftor, lumacaftor\/ivacaftor and elexacaftor\/tezacaftor\/ivacaftor for licensed and off-label use in patients with cystic fibrosis who have named mutations (2022) NHS England. Available at:https:\/\/www.england.nhs.uk\/wp-content\/uploads\/2021\/03\/Commissioning-Statement-CF-modulator-therapies-for-Cystic-Fibrosis-UPDATED-2022.pdf?UNLID=776533918202237122216&UNLID=881855533202312411139 [Accessed 22 January 2023]"},{"key":"10.1016\/j.resmer.2023.101006_bib0022","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jcf.2022.05.014","article-title":"Editorial \u2013 the ethical implications of treating a pregnant woman to benefit the fetus","volume":"21","author":"Bennett","year":"2022","journal-title":"J Cyst Fibros"}],"container-title":["Respiratory Medicine and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041223000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590041223000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:55:14Z","timestamp":1762908914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590041223000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":22,"alternative-id":["S2590041223000181"],"URL":"https:\/\/doi.org\/10.1016\/j.resmer.2023.101006","relation":{},"ISSN":["2590-0412"],"issn-type":[{"value":"2590-0412","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A foetus with cystic fibrosis \u2013 To treat or not to treat?","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine and Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resmer.2023.101006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SPLF and Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101006"}}